Merck (NYSE: MRK) today reported first quarter financial results for the period ended March 31, 2020.
On GAAP basis, first quarter EPS was $1.26 vs. $1.12 in the first quarter of 2019. Non-GAAP EPS was $1.50, compared to $1.22 in the first quarter of 2019.
Total sales increased 11% to $12.05 billion.
Shares down nearly 2% during the pre-market hours following the earnings announcement.
In this challenging and unprecedented time, the quality of our first-quarter performance reflects strong demand for our portfolio of innovative products, continued commercial and clinical execution and the dedication and resilience of our employees around the world. The fundamentals of our business remain strong.Kenneth C. Frazier, Chairman and CEO
You may also like:
COVID-19 puts insurers in tricky situation; risks range from litigation to insolvency
Ravaging almost every part of the world and crippling economic activity, the coronavirus pandemic has not spared any business. When it comes to the insurance industry, the nature of impact is complex and there is no doubt the companies will struggle with their underwriting decisions once the damage is fully assessed.
Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for
After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG
After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many